Is Medibank Private Ltd a smart investment opportunity?

Or should investors avoid Medibank Private Ltd (ASX:MPL) in favour of other opportunities?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As much as I think it is an attractive business with defensive characteristics, I am not a buyer of Medibank at today's prices. There are several reasons:

  • High price (market is optimistic about the company)
  • Poor growth prospects (hard to justify high price)
  • Losing market share to competitors (a sign that business is not meeting customer needs as well as it should be)

My main reason concerns Medibank's market share. First, the business has been the source of myriad customer complaints to the insurance industry ombudsman. Despite having a ~25% market share, last year it accounted for approximately 50% of all industry complaints – although in the company's defense, this has improved markedly in recent times.

Additionally, the rise in insurance prices and Medibank's higher priced insurance have driven customers to cheaper competitors like Bupa, which is now the market leader in Australia.

Market share chart from November 2016 (Source: Company presentation)

If customers are moving to competitors for reasons of price and service, it's hard to get past the idea that Medibank must offer either (or both) better prices and better service in order to win customers. After all, health insurance is a fairly standard product, and will probably become more standardised as companies act to remove confusing, jargonistic, or outdated clauses from their policies.

What's more, because of the above pressures, Medibank is not growing its premiums. Revenue growth at the most recent half year was 1.2%. So to my mind, Medibank is a company that is not growing, and is also exposed to a reasonable risk of lower profits or narrower margins in the future. As a result I think today's share price is optimistic for a company that appears to be getting outdone by competitors.

However, while I am not a buyer of the business today, I am also not predicting catastrophe. Medibank appears exceedingly unlikely to go bankrupt. With its new CEO, and recent investment in new computer systems and more comprehensive customer service departments, I think the company has a good shot at improving its situation. As a result I would consider the business 'Hold' today.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »